缩写名/全名 |
J ONCOL
Journal of Oncology |
||||||||||||||||
ISSN号 | 1687-8450 | ||||||||||||||||
研究方向 | - | ||||||||||||||||
影响因子 | 2015:0, 2016:0, 2017:4.528, 2018:2.6, 2019:2.206, | ||||||||||||||||
出版国家 | |||||||||||||||||
出版周期 | |||||||||||||||||
年文章数 | 231 | ||||||||||||||||
出版年份 | 0 | ||||||||||||||||
是否OA | Yes | ||||||||||||||||
审稿周期(仅供参考) | |||||||||||||||||
录用比例 | |||||||||||||||||
投稿链接 | https://mts.hindawi.com/login/ | ||||||||||||||||
投稿官网 | https://www.hindawi.com/journals/jo/ | ||||||||||||||||
h-index | 47 | ||||||||||||||||
CiteScore |
|
||||||||||||||||
PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1687-8450%5BISSN%5D | ||||||||||||||||
中科院SCI期刊分区 ( 2018年新版本) |
|
||||||||||||||||
中科院SCI期刊分区 ( 2020年新版本) |
|
中国学者近期发表的论文 | |
1. | Prognostic Value of CD133 and SOX2 in Advanced Cancer. Author: Han S1, Huang T2, Wu X1, Wang X1, Liu S1, Yang W1, Shi Q1, Li H1, Hou F1. Journal: J Oncol. 2019 Jan 1;2019:3905817. doi: 10.1155/2019/3905817. eCollection 2019. PubMed DOI |
2. | UBE2C Induces Cisplatin Resistance via ZEB1/2-Dependent Upregulation of ABCG2 and ERCC1 in NSCLC Cells. Author: Wu Y1, Jin D2, Wang X3, Du J1, Di W2, An J4, Shao C2, Guo J1. Journal: J Oncol. 2019 Jan 1;2019:8607859. doi: 10.1155/2019/8607859. eCollection 2019. PubMed DOI |
3. | Low GAS5 Levels as a Predictor of Poor Survival in Patients with Lower-Grade Gliomas. Author: Wang Y1, Xin S1, Zhang K2, Shi R1, Bao X3,4. Journal: J Oncol. 2019 Feb 3;2019:1785042. doi: 10.1155/2019/1785042. eCollection 2019. PubMed DOI |
4. | Mechanism for Regulation of Melanoma Cell Death via Activation of Thermo-TRPV4 and TRPV2. Author: Zheng J1, Liu F1,2, Du S1, Li M1, Wu T1, Tan X2, Cheng W1. Journal: J Oncol. 2019 Feb 7;2019:7362875. doi: 10.1155/2019/7362875. eCollection 2019. PubMed DOI |
5. | Tubal Origin of "Ovarian" Low-Grade Serous Carcinoma: A Gene Expression Profile Study. Author: Wang Y1,2, Hong S3, Mu J1, Wang Y1, Lea J4,5, Kong B6, Zheng W1,2,4,5,7. Journal: J Oncol. 2019 Mar 5;2019:8659754. doi: 10.1155/2019/8659754. eCollection 2019. PubMed DOI |
6. | Clinical Spectrum of Complications Induced by Intravesical Immunotherapy of Bacillus Calmette-Guérin for Bladder Cancer. Author: Liu Y1, Lu J1, Huang Y1, Ma L1. Journal: J Oncol. 2019 Mar 10;2019:6230409. doi: 10.1155/2019/6230409. eCollection 2019. PubMed DOI |
7. | The Significant Influence of the Neuroendocrine Component on the Survival of Patients with Gastric Carcinoma Characterized by Coexisting Exocrine and Neuroendocrine Components. Author: Ren H1, Shi SS2, Wang NC1, Wang X3, Chen YT1, Zhao DB1. Journal: J Oncol. 2019 Mar 12;2019:3671268. doi: 10.1155/2019/3671268. eCollection 2019. PubMed DOI |
8. | Comparative Efficacy and Tolerability of Neoadjuvant Immunotherapy Regimens for Patients with HER2-Positive Breast Cancer: A Network Meta-Analysis. Author: Wu D#1,2, Chen T#3, Jiang H#4, Duan C5, Zhang X6, Lin Y7, Chen S2, Wu F1,2. Journal: J Oncol. 2019 Mar 19;2019:3406972. doi: 10.1155/2019/3406972. eCollection 2019. PubMed DOI |
9. | Characteristics of Mammographic Breast Density and Associated Factors for Chinese Women: Results from an Automated Measurement. Author: Li T1, Tang L2, Gandomkar Z1, Heard R3, Mello-Thoms C1, Xiao Q4, Gu Y4, Di G2, Nickson C5, Shao Z2, Brennan P1. Journal: J Oncol. 2019 Mar 19;2019:4910854. doi: 10.1155/2019/4910854. eCollection 2019. PubMed DOI |
10. | GASC1 Promotes Stemness of Esophageal Squamous Cell Carcinoma via NOTCH1 Promoter Demethylation. Author: Jia R1,2,3,4, Yang L1,2,3, Yuan X4, Kong J4, Liu Y4, Yin W4, Gao S4, Zhang Y1,2,3,5. Journal: J Oncol. 2019 Mar 26;2019:1621054. doi: 10.1155/2019/1621054. eCollection 2019. PubMed DOI |
|
|